Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY: SYK )

364.60 +7.46 (+2.09%)
Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Earnings Preview For Stryker
Via Benzinga
3 Robotics Stocks to Buy and Hold Forever: January 2024
Wager on these top robotics stocks to buy as the industry kicks in to overdrive offering robust long-term upside. 
Via InvestorPlace
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. 
Via Benzinga
How Is The Market Feeling About Stryker?
Via Benzinga
New Intermediate Nail and RC Lag Screw Expand Gamma4 Portfolio to Meet the Needs of Surgeons and Their Patients
From Stryker
Via Business Wire
Navigating 7 Analyst Ratings For Stryker
Via Benzinga
Here's How Much $100 Invested In Stryker 15 Years Ago Would Be Worth Today
Via Benzinga
STRYKER CORP (NYSE:SYK) Technical Analysis observations.
Technical Insights for STRYKER CORP (NYSE:SYK): Is a Breakout Imminent? 
Via Chartmill
Uber, Abbott Laboratories, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management named Crown Castle Inc. 
Via Benzinga
First Shoulder Arthroplasty Surgeries Using Stryker’s Blueprint® Mixed Reality Guidance System Completed at Mayo Clinic in Minnesota and at St. Joseph’s Health Care London in Canada
From Stryker
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The 3 Best Robotics Stocks to Buy in January 2024
Get comprehensive insights on market trends and investment opportunities in the robotics sector, staying ahead in this rapidly evolving world. 
Via InvestorPlace
(SYK) - Analyzing Stryker's Short Interest
Via Benzinga
What Analysts Are Saying About Stryker Stock
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today
Via Benzinga
Stryker announces 2023 sales surpassed $20 billion
From Stryker Corporation
Via GlobeNewswire
Stryker to announce financial results for its fourth quarter and full year 2023
From Stryker Corporation
Via GlobeNewswire
Stryker's Options Frenzy: What You Need to Know
Via Benzinga
Stryker announces intention to nominate a new director, Rachel Ruggeri
From Stryker Corporation
Via GlobeNewswire
Where Stryker Stands With Analysts
Via Benzinga
Peering Into Stryker's Recent Short Interest
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $7,400 Today
Via Benzinga
Stryker announces Dr. Srikant Datar will retire from Board of Directors
From Stryker Corporation
Via GlobeNewswire
Stryker declares a $0.80 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
Medtronic: oversold, overextended high yield reversal in play
The reversal in Medtronic has been brewing for some time but is gaining traction after strong second quarter earnings that came with improved guidance 
Via MarketBeat
Exposures COVID-19
3 Dividend Champions For Long-Term Income
The Dividend Champions have increased their payouts for over a quarter-century. 
Via Talk Markets
Looking Into Stryker's Recent Short Interest
Via Benzinga
The Latest Analyst Ratings for Stryker
Via Benzinga
Stryker Stock Elevated To Top Tier Rating; Fresh Base Forming
Stryker also has a healthy B+ Accumulation/Distribution Rating, showing big investors like mutual funds are fairly heavy buyers of its stock. 
Via Investor's Business Daily
Implants And Joint Replacement Company Stryker Tightens Annual Forecast On 'Positive Procedural Trends'
Stryker Corporation (NYSE: SYK) reported Q3 sales of $4.9 billion, up 9.6% Y/Y (+9.3% in constant currency), beating the consen 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.